COMPANY PROFILE

Tune Therapeutics

Explore full profile

Epigenomics, which is the study of how genes are expressed

Durham, United StatesFounded 2020Biotech & Life Sciences

Valuation $500M–1B Latest valuation · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Tune Therapeutics

Tune Therapeutics operates at the forefront of genetic medicine, leveraging cutting-edge advances in gene regulation to transform human health. The company serves a diverse range of clients, including pharmaceutical companies, research institutions, and healthcare providers, who are focused on innovative treatments for genetic disorders. Tune Therapeutics operates in the biotechnology market, specifically within the niche of epigenetic therapies. Its proprietary platform, TEMPO, allows for precise modulation of gene expression without altering the DNA sequence, offering a novel approach to genetic tuning. The business model is centered around the development and licensing of its genetic tuning technologies, as well as partnerships for clinical trials and therapeutic applications. Revenue is generated through licensing fees, research collaborations, and potential future royalties from successful therapies developed using their platform.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Durham, United States
Employees: 67
Open positions: None listed
Dealroom signal: 61.8/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Tune Therapeutics.

See all news

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Jan 2025	$175M	$900M	NEA · Yosemite · Hevolution · Regeneron Ventures	↗
SERIES AOther financing	Dec 2021	$40M	$160M	Undisclosed	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Tune Therapeutics website traffic

Latest recorded traffic for Tune Therapeutics is 7.3K monthly website visits, up 37.7% over the last three months. Tune Therapeutics's team declined 8.2% over the past year.

Latest monthly visits7.3K 3-month web change+37.7% 1-year team growth-8.2%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
STSolve TherapeuticsTargeted cancer therapies enhancing safety and precision	San Diego, United States	Operational	35	$296M	$480M
NRNucleus RadioPharmaTransforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise	Davidson, United States	Operational
YTYsotope TheranosticsTargeted radiopharmaceuticals for precision oncology	Madrid, Spain	Operational
RORadionetics OncologyRadionetics Oncology is a precision oncology company focusing on the discovery and development of radiopharmaceuticals	San Diego, United States	Operational
ASAtley SolutionsAutomated, standardised and reproducible production of At-211 radiopharmaceuticals for targeted alpha therapy	Göteborgs Stad, Sweden	Operational
PRPrecirixCamelid-derived radiopharmaceuticals for targeted cancer therapy	Jette, Belgium	Operational
ATAsgard TherapeuticsSpin-off company from Lund University focusing on developing cancer immunotherapies based on cell fate reprogramming	Lund Municipality, Sweden	Operational
BTBeijing Immunochina Medical Science and TechnologyBeijing Immunochina Medical Science and Technology is a Chinese medical technology company	Haidian, China	Operational